These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 4617744

  • 21. Current treatment and future prospects of dopa-induced dyskinesias.
    Mazzucchi S, Frosini D, Bonuccelli U, Ceravolo R.
    Drugs Today (Barc); 2015 May; 51(5):315-29. PubMed ID: 26097904
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B, Oliveira C, Mattos JP, Freitas MR.
    Neurol Neurocir Psiquiatr; 1976 May; 17(4):285-92. PubMed ID: 798128
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of Parkinson disease in patients with surgical problems].
    Sobolewski P.
    Neurol Neurochir Pol; 2003 May; 37 Suppl 5():183-8. PubMed ID: 15098345
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D, Friedman A.
    Mov Disord; 2007 May 15; 22(7):1033-6. PubMed ID: 17370308
    [Abstract] [Full Text] [Related]

  • 34. Initiating therapy for Parkinson's disease.
    Silver DE, Ruggieri S.
    Neurology; 1998 Jun 15; 50(6 Suppl 6):S18-22; discussion S44-8. PubMed ID: 9633682
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amantadine therapy in parkinsonism.
    Forssman B, Kihlstrand S, Larsson LE.
    Acta Neurol Scand; 1972 Jun 15; 48(1):1-18. PubMed ID: 4553409
    [No Abstract] [Full Text] [Related]

  • 38. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Calver DM, Zilkha KJ, Knill-Jones RP.
    Lancet; 1970 Feb 07; 1(7641):259-62. PubMed ID: 4189290
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.